- Home
- MODD vs ZYXI Comparison
MODD vs ZYXI Comparison
Compare MODD & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODD
- ZYXI
- Stock Information
- Founded
- MODD 1998
- ZYXI 1996
- Country
- MODD United States
- ZYXI United States
- Employees
- MODD N/A
- ZYXI N/A
- Industry
- MODD Industrial Specialties
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MODD Health Care
- ZYXI Health Care
- Exchange
- MODD Nasdaq
- ZYXI Nasdaq
- Market Cap
- MODD 46.3M
- ZYXI 44.8M
- IPO Year
- MODD N/A
- ZYXI N/A
- Fundamental
- Price
- MODD $0.73
- ZYXI $1.50
- Analyst Decision
- MODD
- ZYXI Hold
- Analyst Count
- MODD 0
- ZYXI 3
- Target Price
- MODD N/A
- ZYXI $3.00
- AVG Volume (30 Days)
- MODD 1.2M
- ZYXI 103.1K
- Earning Date
- MODD 11-13-2025
- ZYXI 10-23-2025
- Dividend Yield
- MODD N/A
- ZYXI N/A
- EPS Growth
- MODD N/A
- ZYXI N/A
- EPS
- MODD N/A
- ZYXI N/A
- Revenue
- MODD N/A
- ZYXI $144,808,000.00
- Revenue This Year
- MODD N/A
- ZYXI N/A
- Revenue Next Year
- MODD N/A
- ZYXI $7.07
- P/E Ratio
- MODD N/A
- ZYXI N/A
- Revenue Growth
- MODD N/A
- ZYXI N/A
- 52 Week Low
- MODD $0.63
- ZYXI $1.23
- 52 Week High
- MODD $2.50
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- MODD 50.78
- ZYXI 42.77
- Support Level
- MODD $0.65
- ZYXI $1.44
- Resistance Level
- MODD $1.00
- ZYXI $1.55
- Average True Range (ATR)
- MODD 0.07
- ZYXI 0.09
- MACD
- MODD 0.00
- ZYXI 0.02
- Stochastic Oscillator
- MODD 20.55
- ZYXI 29.03
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.